This one-day symposium will bring together researchers, physicians, industry professionals, and patient advocates to exchange new knowledge on novel research approaches, expanding our understanding of disease development, novel paths to treatment, and ways to improve the lives of those living with GI and liver disease.
This three-day meeting will convene immuno-oncology experts across academia and industry to share cutting-edge discoveries and to advance the development of novel cancer immunotherapies.
Global experts explore the gene regulation of hemoglobin; the pathophysiology of iron overload, clinical management, emerging therapies, co-morbidities, and updates from clinical trials using gene addition, gene editing, and alternative donor source hematopoietic stem cell transplantation, among other topics central to thalassemia syndromes.
This two-day conference will convene leaders in vaccinology, virology, immunology, biotechnology, microbiology, systems biology, and health policy. Session topics include a look back at advances in vaccine development, updates from present-day vaccinology, a discussion on how vaccine development can be strengthened based on COVID-19 vaccine learnings, pharma company pipeline updates, next generation vaccine adjuvants, improving immune measures, and more.
Researchers are opening up new avenues in our understanding of pain. This symposium will explore dissection of central pain circuits, genetics, biomarkers, emerging therapies, neuro-immune and auto-immune mechanisms, sex and ethnic differences, and innovations in the identification and development of new therapeutic targets for pain.
This symposium will bring together experts in proteostasis biology and neurodegenerative disease, along with clinicians, drug developers, and investors to discuss emerging therapies targeting proteostasis pathways to treat neurodegenerative disease.
Calcium is an essential micronutrient for human health. An estimated 3.5 billion people around the globe are at risk of inadequate dietary intake of calcium. While primarily associated with bone health, calcium has also been shown to reduce the risk of preeclampsia and associated complications, which are leading causes of maternal morbidity and mortality. This webinar is the first in a two-part series on Calcium in Global Health and Nutrition, and will highlight the conclusions of the Calcium Task Force convened by the Nutrition Science Program at The New York Academy of Sciences.
Our genomes are composed of the sum total of genetic material necessary to encode the blueprint for human life. The effective maintenance of genome integrity and stability is essential for normal cell division, normal function of our tissues and organs, healthy aging, and the prevention of diseases such as cancer. The processes that regulate genome integrity maintenance include sensing, signaling, and repair of DNA damage, processing of DNA damage in the context of chromatin and chromosomes, cell cycle checkpoint control, and control of cell death. Many of the basic aspects of genome integrity—such as how cells sense and process DNA damage—are still not well understood.
Our portfolio of events and publications in Genome Integrity seek to successfully map the mechanisms by which these regulatory processes act or go awry, presenting an exciting avenue for identifying novel approaches for protecting against disease-causing errors and restoring function.
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. This year, the symposium will be a full-day program featuring a keynote by Dr. Peter Schulz, Scripps Research Institute.
This symposium will share the latest findings in the study of tumor metabolism, and how altered metabolic pathways can be targeted for cancer therapeutics.